Related Experiment Videos
Multiple differences between wild-type B16 melanoma cells and a wheat germ agglutinin resistant clone
S Di Virgilio1, K P Hellmann, P Robberecht
1Department of General Chemistry I, Université Libre de Bruxelles, Brussels, Belgium.
Anticancer Research
|September 1, 1991
Summary
A B16 murine melanoma variant with altered glycosylation showed reduced metastatic potential. Despite similar invasiveness in vitro, wild-type cells were more lethal in vivo, suggesting glycosylation impacts melanoma metastasis.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- The B16 murine melanoma is a model for studying cancer metastasis.
- Glycosylation, the process of adding carbohydrates to proteins, plays a role in cell surface interactions and cancer progression.
- Wheat germ agglutinin (WGA) is a lectin that binds to specific sugar residues, often used to select for cells with altered glycosylation.
Purpose of the Study:
- To investigate the metastatic potential of a glycosylation-defective B16 murine melanoma variant.
- To compare the invasiveness and in vivo behavior of the variant and wild-type B16 melanoma cells.
- To explore the biochemical differences, including glycosylation patterns and receptor expression, between the variant and wild-type cells.
Main Methods:
- In vitro invasion assays using embryonic chick heart fragments.
- Short-term in vivo arrest assays after intravenous injection.
- Enzyme-level analysis of glycosylation.
- Quantitative analysis of endogenous lectins.
- Assessment of neurotransmitter receptor function (vasoactive intestinal peptide, prostaglandins) and response to cholera toxin.
Main Results:
- The glycosylation-defective variant exhibited reduced metastatic potential in vivo, with wild-type cells causing faster mortality.
- In vitro invasion assays and short-term in vivo arrest assays showed no significant differences between variant and wild-type cells.
- Confirmed alterations in glycosylation at the enzyme level in the variant cells.
- Observed significant quantitative differences in endogenous lectin patterns.
- Variant cells displayed reduced responses to vasoactive intestinal peptide, prostaglandins, and cholera toxin.
Conclusions:
- Altered glycosylation in the B16 melanoma variant is associated with reduced metastatic behavior.
- While altered glycosylation likely contributes to the observed differences, other biochemical changes in the variant cells complicate the identification of the precise mechanisms of metastasis.
- The findings highlight the complex interplay of glycosylation and other cellular factors in determining metastatic potential.